Ligand-Based and Structured-Based In Silico Repurposing Approaches to Predict Inhibitors of SARS-CoV-2 Mpro Protein
- Supplementary File 1:
PDF-Document (PDF, 1059 KiB)
Juárez-Saldívar, A.; Lara-Ramírez, E.E.; Reyes-Espinosa, F.; Paz-González, A.D.; Villalobos-Rocha, J.C.; Rivera, G. Ligand-Based and Structured-Based In Silico Repurposing Approaches to Predict Inhibitors of SARS-CoV-2 Mpro Protein. Sci. Pharm. 2020, 88, 54. https://0-doi-org.brum.beds.ac.uk/10.3390/scipharm88040054
Juárez-Saldívar A, Lara-Ramírez EE, Reyes-Espinosa F, Paz-González AD, Villalobos-Rocha JC, Rivera G. Ligand-Based and Structured-Based In Silico Repurposing Approaches to Predict Inhibitors of SARS-CoV-2 Mpro Protein. Scientia Pharmaceutica. 2020; 88(4):54. https://0-doi-org.brum.beds.ac.uk/10.3390/scipharm88040054
Chicago/Turabian StyleJuárez-Saldívar, Alfredo; Lara-Ramírez, Edgar E.; Reyes-Espinosa, Francisco; Paz-González, Alma D.; Villalobos-Rocha, Juan C.; Rivera, Gildardo. 2020. "Ligand-Based and Structured-Based In Silico Repurposing Approaches to Predict Inhibitors of SARS-CoV-2 Mpro Protein" Sci. Pharm. 88, no. 4: 54. https://0-doi-org.brum.beds.ac.uk/10.3390/scipharm88040054